President Trump signed an executive order to reduce prescription drug prices by implementing a 'most favored nation's policy' to match the lowest prices paid by other countries. He criticized drug companies for charging Americans more and vowed to take action to lower costs. The order targets GLP-1 weight loss drugs, which have significant price disparities between the U.S. and other nations.